Invention Grant
US08530167B2 Diagnostic and therapeutic uses of GNPTAB, GNPTG, and NAGPA in stuttering
有权
GNPTAB，GNPTG和NAGPA在口吃中的诊断和治疗用途
- Patent Title: Diagnostic and therapeutic uses of GNPTAB, GNPTG, and NAGPA in stuttering
- Patent Title (中): GNPTAB，GNPTG和NAGPA在口吃中的诊断和治疗用途
-
Application No.: US13148340Application Date: 2010-02-08
-
Publication No.: US08530167B2Publication Date: 2013-09-10
- Inventor: Dennis T. Drayna , Changsoo Paul Kang , Sheikh Riazuddin
- Applicant: Dennis T. Drayna , Changsoo Paul Kang , Sheikh Riazuddin
- Applicant Address: US DC Washington PK Lahore
- Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services,Centre of Excellence in Molecular Biology Together With All Allied Components, University of Punjab
- Current Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services,Centre of Excellence in Molecular Biology Together With All Allied Components, University of Punjab
- Current Assignee Address: US DC Washington PK Lahore
- Agency: Leydig, Voit & Mayer
- International Application: PCT/US2010/023437 WO 20100208
- International Announcement: WO2010/091328 WO 20100812
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C07H21/04
Abstract:
The allelic variants or mutations in three genes: GNPTAB, GNPTG and NAGPA, that correlate with stuttering in humans, as well as the encoded mutated polypeptides and related vectors, host cells, antibodies, antibody-producing cell lines and methods of diagnosing, prognosticating and treating stuttering are provided.
Public/Granted literature
- US20110313029A1 DIAGNOSTIC AND THERAPEUTIC USES OF GNPTAB, GNPTG, AND NAGPA IN STUTTERING Public/Granted day:2011-12-22
Information query
